JP2024538751A5 - - Google Patents
Info
- Publication number
- JP2024538751A5 JP2024538751A5 JP2024521318A JP2024521318A JP2024538751A5 JP 2024538751 A5 JP2024538751 A5 JP 2024538751A5 JP 2024521318 A JP2024521318 A JP 2024521318A JP 2024521318 A JP2024521318 A JP 2024521318A JP 2024538751 A5 JP2024538751 A5 JP 2024538751A5
- Authority
- JP
- Japan
- Prior art keywords
- immune cells
- memory
- cells
- modified
- human immune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163253058P | 2021-10-06 | 2021-10-06 | |
| US63/253,058 | 2021-10-06 | ||
| PCT/US2022/077721 WO2023060212A1 (en) | 2021-10-06 | 2022-10-06 | Enhancing adoptive cell transfer by promoting a superior population of adaptive immune cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538751A JP2024538751A (ja) | 2024-10-23 |
| JP2024538751A5 true JP2024538751A5 (https=) | 2025-10-15 |
Family
ID=83996498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024521318A Pending JP2024538751A (ja) | 2021-10-06 | 2022-10-06 | 優れた適応免疫細胞の集団を促進することによる養子細胞移入の増強 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240398950A1 (https=) |
| EP (1) | EP4412627A1 (https=) |
| JP (1) | JP2024538751A (https=) |
| CN (1) | CN118541160A (https=) |
| AU (1) | AU2022361057A1 (https=) |
| CA (1) | CA3233989A1 (https=) |
| WO (1) | WO2023060212A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119816589A (zh) * | 2022-08-02 | 2025-04-11 | 国立大学法人北海道大学 | 使用细胞器复合体改善细胞疗法的方法 |
| AU2024270764A1 (en) | 2023-05-15 | 2025-12-04 | Nchroma Bio, Inc. | Compositions and methods for epigenetic regulation of hbv gene expression |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2832540C (en) | 2011-04-08 | 2020-09-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer |
| CN106536056B (zh) | 2014-06-13 | 2021-07-16 | 儿童医学中心公司 | 分离线粒体的产品和方法 |
| KR101846464B1 (ko) * | 2016-11-14 | 2018-04-09 | 주식회사 파이안바이오테크놀로지 | 외래 미토콘드리아를 포함하는 자연살해세포 및 이를 포함하는 약학적 조성물 |
| WO2020102321A1 (en) * | 2018-11-13 | 2020-05-22 | Abraham J And Phyllis Katz Cord Blood Foundation | T cells with improved mitochondrial function |
| CN116096861A (zh) * | 2020-04-03 | 2023-05-09 | 赛立维公司 | 过继性细胞转移的增强 |
-
2022
- 2022-10-06 EP EP22797236.1A patent/EP4412627A1/en active Pending
- 2022-10-06 CN CN202280080879.8A patent/CN118541160A/zh active Pending
- 2022-10-06 JP JP2024521318A patent/JP2024538751A/ja active Pending
- 2022-10-06 AU AU2022361057A patent/AU2022361057A1/en active Pending
- 2022-10-06 WO PCT/US2022/077721 patent/WO2023060212A1/en not_active Ceased
- 2022-10-06 CA CA3233989A patent/CA3233989A1/en active Pending
- 2022-10-06 US US18/699,134 patent/US20240398950A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MacDonald et al. | Methods to manufacture regulatory T cells for cell therapy | |
| JP6031021B2 (ja) | 細胞治療のためのｔ細胞を調製するための方法 | |
| Shimasaki et al. | Expanded and armed natural killer cells for cancer treatment | |
| JP2024538751A5 (https=) | ||
| JP2021509586A5 (https=) | ||
| JP2018531035A5 (https=) | ||
| Ye et al. | Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes | |
| JP2018515108A (ja) | 準静的細胞培養 | |
| JPH10507627A (ja) | Ｔリンパ球のインビトロ増殖の急速拡大方法（「ｒｅｍ」） | |
| JP2022191501A (ja) | 多能性幹細胞からヘルパーｔ細胞を製造する方法 | |
| JP2022501031A5 (https=) | ||
| JP2022554348A5 (https=) | ||
| JP2019522984A5 (https=) | ||
| JP2023503061A5 (https=) | ||
| Li et al. | Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells | |
| JP2024535002A5 (https=) | ||
| JP2025504002A5 (https=) | ||
| JP2020191873A5 (https=) | ||
| JP2023530419A5 (https=) | ||
| US20230089392A1 (en) | Monocyte depletion of t cells populations for t-cell therapy | |
| JPWO2023033124A5 (https=) | ||
| JPWO2021100585A5 (https=) | ||
| Lim et al. | A GD Type of Cancel Culture | |
| CN115838432A (zh) | 一种靶向调控抗原特异性t细胞的融合蛋白及应用 | |
| CN119307444A (zh) | 细胞治疗产品制备工艺及其应用 |